on LR Health & Beauty SE (isin : NO0013149658)
LR Health & Beauty SE Confirms 2025 Financial Figures and Strategic Progress
LR Health & Beauty SE has published its final annual report for 2025, confirming sales of EUR 277.1 million, slightly down from EUR 289.2 million in 2024. The company reported an EBITDA of EUR 16.5 million, affected by restructuring costs, compared to EUR 27.3 million the previous year. Normalized EBITDA stood at EUR 22.5 million.
CEO Jörg Körfer highlighted 2026 as a year of transition, emphasizing the new financing structure's support for strategic growth. LR plans to invest over EUR 2 million in a centralized production line in Ahlen, focused on its 5in1 product range, with an annual capacity of 40 million units.
The full report is available on their website, detailing these initiatives aimed at enhancing their production and international sales efforts.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all LR Health & Beauty SE news